Analysed QUINCE THERAPEUTICS INC (QNCX:NASDAQ) News Sources
Quince Therapeutics’ stock crashes on Phase III ataxia-telangiectasia failure
02-02-2026
clinicaltrialsarena.com
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
18-05-2026
yahoo.com
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18-05-2026
yahoo.com
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18-05-2026
yahoo.com
Quince Therapeutics Inc. (QNCX) Presents Positive Phase 2a Data for LAM-001 Inhaled Therapy
02-06-2026
yahoo.com
What is the current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is $17.25.
QUINCE THERAPEUTICS INC (QNCX:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is $-0.29.
QUINCE THERAPEUTICS INC (QNCX:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is -1.6534%.
What is the most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The most recent sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is .
SEC-8K** Filing Available For QUINCE THERAPEUTICS INC (QNCX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.